You are here: Industry Insights > Pharma?Experts

News List

Paracetamol from Plastic: Terephthalic Acid as a Sustainable Pharmaceutical Intermediate David Orchard-Webb
July 08, 2025
In the fast-paced pharmaceutical industry, where innovation and efficiency drive success, sustainability is also increasingly a concern given the limited nature of natural resources (Swaminathan, 2024).
Predicted Top 5 Worldwide Selling Generic or Biosimilar Drugs in 2025 David Orchard-Webb
July 08, 2025
The global pharmaceutical market is approaching a phase in which several high-revenue medicines will lose patent protection, paving the way for generic and biosimilar competition (Scheckel, 2021).
Predicted Top 5 Worldwide Selling Drugs in 2025: A Market Update David Orchard-Webb
June 23, 2025
Keytruda ($30B sales), Ozempic, Mounjaro, Dupixent, and Skyrizi dominate 2025's pharma market, targeting oncology, diabetes/obesity, and immunology with breakthrough biologics and multi-indication strategies.
Diabetes and Metabolic Disorders: The Approval of Teplizumab David Orchard-Webb
June 23, 2025
Teplizumab, the first disease-modifying therapy for Type 1 diabetes, delays disease onset by ~4 years in high-risk individuals. Priced at $194,000 per course, it redefines early intervention despite cost barriers.
Pharmacovigilance Regulations and Application: Safeguarding Drug Safety in a Complex Global Environment David Orchard-Webb
May 06, 2025
In a pharmaceutical world characterized by rapid innovation and international marketplaces, safeguarding medication safety beyond commercialization has never been more important.
Sterilization Processes in the Pharmaceutical Industry David Orchard-Webb
May 06, 2025
In this post, we'll look at the numerous sterilization techniques utilized in the pharmaceutical sector, as well as their uses and benefits in terms of product safety and regulatory compliance.
The Transformative Role of Blockchain in the Pharmaceutical Industry David Orchard-Webb
April 21, 2025
The pharmaceutical business, long considered one of the most regulated and difficult sectors, is experiencing a digital transition.
The Global ESG Rules and Regulations in the Pharmaceutical Industry: AstraZeneca Case Study David Orchard-Webb
April 21, 2025
In the dynamic pharmaceutical sector, where innovation and regulatory compliance have long been the pillars of success, a new disruptive force is emerging: Environmental, Social, and Governance (ESG) principles
Global Shingles (Herpes Zoster) Market Trends and Prospects David Orchard-Webb
March 18, 2025
The global shingles market is growing due to factors like an aging population. It elaborates on drivers, segmentation, competition, and future trends.
The Global Alpha-Glucosidase Inhibitor Market: Trends and Prospects David Orchard-Webb
March 18, 2025
Alpha-glucosidase inhibitors are used for type 2 diabetes. This article analyzes their market, including growth, segments, and challenges.